Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis
There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end‐stage renal disease patients undergoing...
Uloženo v:
| Vydáno v: | Journal of cachexia, sarcopenia and muscle Ročník 13; číslo 1; s. 145 - 158 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Germany
John Wiley & Sons, Inc
01.02.2022
John Wiley and Sons Inc Wiley |
| Témata: | |
| ISSN: | 2190-5991, 2190-6009, 2190-6009 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end‐stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual‐energy X‐ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty‐two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut‐off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9–34.1%) and varied from 25.9% (I2 = 94.9%, 95% CI 20.4–31.3%; combined criteria) to 34.6% (I2 = 98.1%, 95% CI 20.9–48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: −0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI −0.002 to 0.005), P = 0.327] in the meta‐regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I2 = 26.3%, 95% CI 1.38–2.39)], as was LMM [HR 1.61 (I2 = 26.0%, 95% CI 1.31–1.99)] and low muscle strength [HR 2.04 (I2 = 80.4%, 95% CI 1.19–3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. |
|---|---|
| AbstractList | There is no consensus on the prevalence of sarcopenia or its impact on mortality in end-stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end-stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual-energy X-ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I
test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty-two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut-off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9-34.1%) and varied from 25.9% (I
= 94.9%, 95% CI 20.4-31.3%; combined criteria) to 34.6% (I
= 98.1%, 95% CI 20.9-48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: -0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI -0.002 to 0.005), P = 0.327] in the meta-regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I
= 26.3%, 95% CI 1.38-2.39)], as was LMM [HR 1.61 (I
= 26.0%, 95% CI 1.31-1.99)] and low muscle strength [HR 2.04 (I
= 80.4%, 95% CI 1.19-3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end‐stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual‐energy X‐ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I 2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty‐two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut‐off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9–34.1%) and varied from 25.9% ( I 2 = 94.9%, 95% CI 20.4–31.3%; combined criteria) to 34.6% ( I 2 = 98.1%, 95% CI 20.9–48.2%; LMM alone) ( P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria ( P > 0.05) and dialysis modality ( P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: −0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI −0.002 to 0.005), P = 0.327] in the meta‐regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 ( I 2 = 26.3%, 95% CI 1.38–2.39)], as was LMM [HR 1.61 ( I 2 = 26.0%, 95% CI 1.31–1.99)] and low muscle strength [HR 2.04 ( I 2 = 80.4%, 95% CI 1.19–3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end‐stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual‐energy X‐ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I 2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty‐two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut‐off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9–34.1%) and varied from 25.9% (I 2 = 94.9%, 95% CI 20.4–31.3%; combined criteria) to 34.6% (I 2 = 98.1%, 95% CI 20.9–48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: −0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI −0.002 to 0.005), P = 0.327] in the meta‐regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I 2 = 26.3%, 95% CI 1.38–2.39)], as was LMM [HR 1.61 (I 2 = 26.0%, 95% CI 1.31–1.99)] and low muscle strength [HR 2.04 (I 2 = 80.4%, 95% CI 1.19–3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. Abstract There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end‐stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual‐energy X‐ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty‐two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut‐off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9–34.1%) and varied from 25.9% (I2 = 94.9%, 95% CI 20.4–31.3%; combined criteria) to 34.6% (I2 = 98.1%, 95% CI 20.9–48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: −0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI −0.002 to 0.005), P = 0.327] in the meta‐regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I2 = 26.3%, 95% CI 1.38–2.39)], as was LMM [HR 1.61 (I2 = 26.0%, 95% CI 1.31–1.99)] and low muscle strength [HR 2.04 (I2 = 80.4%, 95% CI 1.19–3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end‐stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual‐energy X‐ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty‐two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut‐off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9–34.1%) and varied from 25.9% (I2 = 94.9%, 95% CI 20.4–31.3%; combined criteria) to 34.6% (I2 = 98.1%, 95% CI 20.9–48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: −0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI −0.002 to 0.005), P = 0.327] in the meta‐regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I2 = 26.3%, 95% CI 1.38–2.39)], as was LMM [HR 1.61 (I2 = 26.0%, 95% CI 1.31–1.99)] and low muscle strength [HR 2.04 (I2 = 80.4%, 95% CI 1.19–3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. There is no consensus on the prevalence of sarcopenia or its impact on mortality in end-stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end-stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual-energy X-ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty-two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut-off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9–34.1%) and varied from 25.9% (I2 = 94.9%, 95% CI 20.4–31.3%; combined criteria) to 34.6% (I2 = 98.1%, 95% CI 20.9–48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: −0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI −0.002 to 0.005), P = 0.327] in the meta-regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I2 = 26.3%, 95% CI 1.38–2.39)], as was LMM [HR 1.61 (I2 = 26.0%, 95% CI 1.31–1.99)] and low muscle strength [HR 2.04 (I2 = 80.4%, 95% CI 1.19–3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. There is no consensus on the prevalence of sarcopenia or its impact on mortality in end-stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end-stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual-energy X-ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty-two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut-off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9-34.1%) and varied from 25.9% (I2 = 94.9%, 95% CI 20.4-31.3%; combined criteria) to 34.6% (I2 = 98.1%, 95% CI 20.9-48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: -0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI -0.002 to 0.005), P = 0.327] in the meta-regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I2 = 26.3%, 95% CI 1.38-2.39)], as was LMM [HR 1.61 (I2 = 26.0%, 95% CI 1.31-1.99)] and low muscle strength [HR 2.04 (I2 = 80.4%, 95% CI 1.19-3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients.There is no consensus on the prevalence of sarcopenia or its impact on mortality in end-stage renal disease patients undergoing dialysis. This review aimed to summarize the diagnostic criteria of sarcopenia and its prevalence and impact on the mortality of end-stage renal disease patients undergoing dialysis. Embase, MEDLINE, PubMed, and Cochrane Library were searched from inception to 8 May 2021 to retrieve eligible studies that assessed muscle mass by commonly used instruments, such as dual-energy X-ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and body composition monitor. Two assessment tools matched to study designs were employed to evaluate study quality. Pooled sarcopenia prevalence was calculated with 95% confidence interval (CI), and heterogeneity was estimated using the I2 test. Associations of sarcopenia with mortality were expressed as hazard ratio (HR) and 95% CI. The search identified 3272 studies, and 30 studies (6162 participants, mean age from 47.5 to 77.5 years) were analysed in this review. The risk of bias in the included studies was low to moderate. Twenty-two studies defined sarcopenia based on low muscle mass (LMM) plus low muscle strength and/or low physical performance, while eight studies used LMM alone. Muscle mass was assessed by different instruments, and a wide range of cut-off points were used to define LMM. Overall, sarcopenia prevalence was 28.5% (95% CI 22.9-34.1%) and varied from 25.9% (I2 = 94.9%, 95% CI 20.4-31.3%; combined criteria) to 34.6% (I2 = 98.1%, 95% CI 20.9-48.2%; LMM alone) (P = 0.247 between subgroups). The statistically significant differences were not found in the subgroups of diagnostic criteria (P > 0.05) and dialysis modality (P > 0.05). Additionally, the sarcopenia prevalence could not be affected by average age [regression coefficient 0.004 (95% CI: -0.005 to 0.012), P = 0.406] and dialysis duration [regression coefficient 0.002 (95% CI -0.002 to 0.005), P = 0.327] in the meta-regression. The pooled analyses showed that combined criteria of sarcopenia were related to a higher mortality risk [HR 1.82 (I2 = 26.3%, 95% CI 1.38-2.39)], as was LMM [HR 1.61 (I2 = 26.0%, 95% CI 1.31-1.99)] and low muscle strength [HR 2.04 (I2 = 80.4%, 95% CI 1.19-3.5)]. Although there are substantial differences in diagnostic criteria, sarcopenia is highly prevalent in dialysis patients and is linked to increased mortality. The standardization of sarcopenia diagnostic criteria would be beneficial, and future longitudinal studies are needed to investigate the prevalence and prognostic value of sarcopenia in dialysis patients. |
| Author | Shu, Xiaoyu Jiang, Tingting Yue, Jirong Wang, Hui Lin, Taiping Peng, Xuchao Zhao, Yanli |
| AuthorAffiliation | 1 Department of Geriatrics, West China Hospital Sichuan University Chengdu Sichuan China 2 National Clinical Research Center for Geriatrics, West China Hospital Sichuan University Chengdu Sichuan China |
| AuthorAffiliation_xml | – name: 1 Department of Geriatrics, West China Hospital Sichuan University Chengdu Sichuan China – name: 2 National Clinical Research Center for Geriatrics, West China Hospital Sichuan University Chengdu Sichuan China |
| Author_xml | – sequence: 1 givenname: Xiaoyu surname: Shu fullname: Shu, Xiaoyu organization: Sichuan University – sequence: 2 givenname: Taiping surname: Lin fullname: Lin, Taiping organization: Sichuan University – sequence: 3 givenname: Hui surname: Wang fullname: Wang, Hui organization: Sichuan University – sequence: 4 givenname: Yanli surname: Zhao fullname: Zhao, Yanli organization: Sichuan University – sequence: 5 givenname: Tingting surname: Jiang fullname: Jiang, Tingting organization: Sichuan University – sequence: 6 givenname: Xuchao surname: Peng fullname: Peng, Xuchao organization: Sichuan University – sequence: 7 givenname: Jirong orcidid: 0000-0002-3730-779X surname: Yue fullname: Yue, Jirong email: yuejirong11@hotmail.com organization: Sichuan University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34989172$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1DAUhiNURC90wwMgS2xQ1Sm24zg2CyQ03IqKWABr64xzMniU2KmdaTU7HoFn5EnwNENFK4Q3sZzv_3Tscw6LPR88FsUTRs8YpfzFyqb-jHGl6YPigDNNZ5JSvbfbV1qz_eI4pRXNS0gmK_qo2C-FVprV_KAY3jhY-pBcOiVDxCvo0Fs8JeAb0oc4QufGDQktSRBtGNA7IM6TxkG3ySEywOjQj-klAZI2acQ-H1iSTQ6vJwuO8OvHT_BT4nHxsIUu4fHue1R8e_f26_zD7OLz-_P564uZrRSlM-ALSW0jtFZQg63rdsGk5Si44Kh0haqlDEshBVO6RAC2qJls2loJW5dUlkfF-eRtAqzMEF0PcWMCOHNzEOLSQMyldmiorGuBomqFUqJsS93wphRl2VBVacsgu15NrmG96LGx-cIRujvSu3-8-26W4cooxZSkOgue7wQxXK4xjaZ3yWLXgcewTobL3IxalqLO6LN76CqsY368LcUrzbmuVKae_l3RbSl_GpuBkwmwMaQUsb1FGDXbwTHbwTE3g5Nheg-2bsx9DNvbuO7fETZFrl2Hm__Izcf5l09T5jdDo9Z4 |
| CitedBy_id | crossref_primary_10_3390_ijms26168096 crossref_primary_10_3389_fendo_2024_1437379 crossref_primary_10_1016_j_nut_2025_112795 crossref_primary_10_1111_jocn_17755 crossref_primary_10_7717_peerj_14429 crossref_primary_10_1016_j_metabol_2023_155533 crossref_primary_10_3389_fmed_2025_1649113 crossref_primary_10_1053_j_jrn_2024_05_003 crossref_primary_10_1111_sdi_13131 crossref_primary_10_1080_0886022X_2022_2128373 crossref_primary_10_1053_j_jrn_2024_07_005 crossref_primary_10_1007_s11255_022_03393_0 crossref_primary_10_1002_ncp_11227 crossref_primary_10_1080_0886022X_2025_2519822 crossref_primary_10_3389_fendo_2024_1402551 crossref_primary_10_12968_hmed_2024_0298 crossref_primary_10_3389_fnut_2023_1069651 crossref_primary_10_1016_j_ejim_2023_11_015 crossref_primary_10_1186_s12882_024_03487_0 crossref_primary_10_1038_s41598_023_49658_1 crossref_primary_10_1038_s41598_024_77725_8 crossref_primary_10_1186_s12889_024_21198_x crossref_primary_10_1016_j_xkme_2025_100989 crossref_primary_10_1053_j_jrn_2025_03_005 crossref_primary_10_1016_j_clnesp_2025_03_019 crossref_primary_10_3389_fendo_2023_1117438 crossref_primary_10_1016_j_nut_2024_112566 crossref_primary_10_1053_j_jrn_2024_05_012 crossref_primary_10_1590_0034_7167_2022_0677 crossref_primary_10_1097_jagr_0000000000000034 crossref_primary_10_1016_j_clnesp_2023_06_002 crossref_primary_10_1038_s41598_023_31184_9 crossref_primary_10_1177_23337214241253433 crossref_primary_10_1007_s00774_024_01503_9 crossref_primary_10_1053_j_jrn_2024_05_009 crossref_primary_10_1007_s40620_024_02191_4 crossref_primary_10_1016_j_clnu_2025_08_005 crossref_primary_10_1186_s12882_024_03587_x crossref_primary_10_1186_s12877_024_04691_1 crossref_primary_10_1016_j_clnesp_2024_07_1059 crossref_primary_10_23946_2500_0764_2025_10_1_75_86 crossref_primary_10_1002_jcsm_13331 crossref_primary_10_1038_s41598_023_33545_w crossref_primary_10_2490_prm_20250012 crossref_primary_10_3389_fnut_2023_1223975 crossref_primary_10_3390_nu17142323 crossref_primary_10_1016_j_cnd_2025_02_003 crossref_primary_10_1038_s41598_022_18492_2 crossref_primary_10_1053_j_jrn_2025_01_002 crossref_primary_10_3389_fmed_2023_1160450 crossref_primary_10_3390_nu17152525 crossref_primary_10_1080_09638288_2025_2554947 crossref_primary_10_1016_j_maturitas_2025_108233 crossref_primary_10_1186_s43162_024_00388_4 crossref_primary_10_1007_s11255_022_03392_1 crossref_primary_10_1111_ggi_14877 crossref_primary_10_1016_j_jchf_2025_01_016 crossref_primary_10_1159_000547710 crossref_primary_10_1186_s12882_023_03084_7 crossref_primary_10_1111_iju_15539 crossref_primary_10_3389_fmed_2025_1517765 crossref_primary_10_3389_fpubh_2022_996447 crossref_primary_10_3390_nu17071237 crossref_primary_10_1080_0886022X_2024_2367026 crossref_primary_10_1016_j_clnesp_2023_11_012 crossref_primary_10_3390_ijerph19148866 crossref_primary_10_1186_s12890_025_03901_9 crossref_primary_10_1016_j_biopha_2024_116556 crossref_primary_10_1002_jcsm_70018 crossref_primary_10_1186_s41100_025_00634_7 crossref_primary_10_1007_s00595_023_02751_4 crossref_primary_10_1002_jcsm_13311 crossref_primary_10_1002_jcsm_13275 crossref_primary_10_1016_j_surg_2024_08_028 crossref_primary_10_1038_s41598_024_74709_6 crossref_primary_10_1371_journal_pone_0330767 crossref_primary_10_3389_fendo_2024_1293146 crossref_primary_10_1002_jcsm_13425 crossref_primary_10_1053_j_jrn_2024_06_006 crossref_primary_10_1186_s12882_024_03787_5 crossref_primary_10_3390_nu14194077 crossref_primary_10_3389_fphys_2023_1092352 crossref_primary_10_1159_000538980 crossref_primary_10_3389_fendo_2023_1215512 crossref_primary_10_1016_j_jnha_2025_100484 crossref_primary_10_1053_j_jrn_2025_04_001 crossref_primary_10_3389_fimmu_2022_878755 crossref_primary_10_3389_fmed_2025_1606430 crossref_primary_10_3390_jfmk8030092 crossref_primary_10_1186_s12882_023_03445_2 crossref_primary_10_1007_s40520_024_02911_7 crossref_primary_10_3389_fmed_2025_1525205 crossref_primary_10_3390_medicina61030449 crossref_primary_10_1053_j_jrn_2023_08_005 crossref_primary_10_1177_1973798X251340155 crossref_primary_10_1080_0886022X_2025_2520908 crossref_primary_10_1186_s12891_025_08291_x crossref_primary_10_1016_j_cdnut_2022_100014 crossref_primary_10_2147_CIA_S440967 crossref_primary_10_1186_s12889_023_17091_8 crossref_primary_10_3390_nu16203467 crossref_primary_10_1186_s12882_025_03963_1 crossref_primary_10_1038_s41598_024_65130_0 crossref_primary_10_3389_fendo_2023_1309645 crossref_primary_10_1097_MCO_0000000000001022 crossref_primary_10_3390_medicina61061044 crossref_primary_10_1002_jcsm_13130 crossref_primary_10_1016_j_arr_2024_102601 crossref_primary_10_3389_fendo_2023_1181139 crossref_primary_10_1186_s12882_024_03836_z crossref_primary_10_1097_MNH_0000000000000834 crossref_primary_10_2147_CLEP_S416778 crossref_primary_10_7717_peerj_16909 crossref_primary_10_1016_j_mayocp_2023_11_008 crossref_primary_10_1007_s12928_025_01136_3 crossref_primary_10_1186_s12882_022_02942_0 crossref_primary_10_1016_j_jtemb_2024_127465 crossref_primary_10_3389_fnut_2024_1465486 crossref_primary_10_1590_0034_7167_2022_0677pt crossref_primary_10_2147_IJNRD_S532499 crossref_primary_10_1177_10784535241239684 crossref_primary_10_1002_jcsm_13400 crossref_primary_10_3233_JAD_230196 crossref_primary_10_1080_0886022X_2023_2182608 crossref_primary_10_3389_fmed_2022_1116702 crossref_primary_10_1016_j_asjsur_2023_12_118 crossref_primary_10_1016_j_bone_2023_116975 crossref_primary_10_1155_2023_4310809 crossref_primary_10_1016_j_clnu_2025_07_028 crossref_primary_10_1371_journal_pone_0328757 crossref_primary_10_1007_s40620_024_02147_8 crossref_primary_10_1016_j_ajcnut_2024_10_010 crossref_primary_10_1186_s12882_022_02973_7 crossref_primary_10_1002_ncp_10967 crossref_primary_10_1016_j_arr_2022_101739 crossref_primary_10_1038_s41598_024_59995_4 crossref_primary_10_1111_nep_70018 crossref_primary_10_3390_ijerph19073873 crossref_primary_10_1016_j_ajt_2023_11_002 crossref_primary_10_1097_MCO_0000000000000871 crossref_primary_10_1016_j_phymed_2025_157190 crossref_primary_10_1002_jcsm_13113 crossref_primary_10_1177_08968608241288958 crossref_primary_10_1053_j_jrn_2023_10_008 crossref_primary_10_1186_s12882_023_03283_2 crossref_primary_10_1002_jcsm_13078 crossref_primary_10_2147_DMSO_S479900 |
| Cites_doi | 10.3747/pdi.2017.00271 10.1152/japplphysiol.00246.2003 10.1016/j.cmet.2013.07.012 10.1016/j.jamda.2019.12.012 10.2215/CJN.10261013 10.1038/s41430-018-0238-3 10.1093/aje/kwh058 10.1038/nrneph.2014.112 10.3109/0886022X.2015.1132173 10.1038/ejcn.2016.202 10.2337/db09-0525 10.1046/j.1532-5415.2003.51534.x 10.1016/j.clnu.2020.07.025 10.1111/ggi.14089 10.1016/j.pcad.2018.07.001 10.1016/j.cmet.2015.11.003 10.1038/s41430-019-0468-z 10.1053/j.jrn.2017.12.003 10.1053/j.jrn.2016.09.010 10.1093/ndt/gfy252 10.1038/sj.ki.5002585 10.1016/j.clnu.2016.10.016 10.1016/S0140-6736(16)30448-2 10.1186/s12882-018-1055-6 10.1016/j.pcad.2013.10.005 10.1093/oxfordjournals.aje.a009520 10.1016/j.jfma.2019.10.020 10.1371/journal.pmed.1003583 10.2215/CJN.08550814 10.1007/s40620-020-00840-y 10.1002/jcsm.12501 10.1007/s40620-020-00871-5 10.1111/j.1532-5415.2008.01854.x 10.1046/j.1525-139X.2002.00083.x 10.1186/s12882-020-01937-z 10.1016/j.kint.2017.07.022 10.1016/j.kint.2017.01.024 10.3747/pdi.2013.00217 10.1007/s13539-011-0026-6 10.1159/000095327 10.1016/j.clnu.2008.04.004 10.1136/bmj.315.7109.629 10.1111/jhn.12555 10.1016/j.jclinepi.2011.11.014 10.1093/ageing/afq034 10.1093/gerona/glp097 10.1248/bpb.b19-00513 10.1371/journal.pone.0195485 10.1007/s12603-014-0505-5 10.1016/j.cca.2018.06.025 10.1093/gerona/glu010 10.3747/pdi.2016.00019 10.1053/j.jrn.2013.01.001 10.1038/ejcn.2017.104 10.1093/ajcn/81.3.543 10.1016/S0272-6386(97)90342-5 10.1136/bmj.327.7414.557 10.1038/ki.2013.252 10.1186/s12882-019-1271-8 10.1053/j.jrn.2019.09.004 10.1016/j.jamda.2013.11.025 10.1038/s41430-017-0072-z 10.1097/MCO.0000000000000171 10.1016/j.ecl.2012.04.012 10.1056/NEJMoa0904655 10.1093/ndt/gft070 10.1016/j.numecd.2019.05.057 10.1016/j.jamda.2011.01.003 10.1016/j.jclinepi.2009.06.006 10.1371/journal.pone.0007038 10.1046/j.1532-5415.2002.50216.x 10.3904/kjim.2017.083 10.2307/2533446 10.3389/fped.2018.00161 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. – notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1002/jcsm.12890 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Diagnosis, prevalence, and mortality of sarcopenia |
| EISSN | 2190-6009 |
| EndPage | 158 |
| ExternalDocumentID | oai_doaj_org_article_06774e45f48843f39d2d3433d0859c1a PMC8818609 34989172 10_1002_jcsm_12890 JCSM12890 |
| Genre | reviewArticle Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GrantInformation_xml | – fundername: National Science & Technology Pillar Program funderid: 2020YFC2005600/02 – fundername: Sichuan University funderid: Z2018B13; Z20191003; 19HXFH012; ZYJC21005 – fundername: Sichuan Province Science and Technology Support Program funderid: 2019YFS0277; 2021YFS0136 – fundername: ; grantid: Z2018B13; Z20191003; 19HXFH012; ZYJC21005 – fundername: ; grantid: 2019YFS0277; 2021YFS0136 – fundername: National Science & Technology Pillar Program grantid: 2020YFC2005600/02 |
| GroupedDBID | --- 0R~ 1OC 24P 2VQ 4.4 40G 53G 5VS 7X7 8FI 8FJ AAHHS AAKDD AAZKR ABUWG ACCFJ ACCMX ACXQS ADBBV ADINQ ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFKRA AHBYD AHSBF AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AOIJS AVUZU AZFZN BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK EBS EJD EMOBN FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH ITC KQ8 M48 M~E O9- OK1 OVD OVEED PIMPY PQQKQ PROAC RPM RSV SMD SOJ U2A UKHRP WIN ZOVNA AAFWJ AAMMB AAYXX AEFGJ AFFHD AFPKN AGXDD AIDQK AIDYY CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c5800-a2b60cd4998a7ac77fb16c2e4242e895e8f01e34641893eaa1b716df784c73063 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 168 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000739132300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2190-5991 2190-6009 |
| IngestDate | Fri Oct 03 12:46:16 EDT 2025 Tue Nov 04 02:02:21 EST 2025 Wed Oct 01 14:45:15 EDT 2025 Tue Oct 07 07:15:13 EDT 2025 Mon Jul 21 06:06:25 EDT 2025 Sat Nov 29 04:06:40 EST 2025 Tue Nov 18 21:59:46 EST 2025 Wed Jan 22 16:27:17 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Sarcopenia Dialysis Prevalence Diagnosis Mortality |
| Language | English |
| License | Attribution 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5800-a2b60cd4998a7ac77fb16c2e4242e895e8f01e34641893eaa1b716df784c73063 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| ORCID | 0000-0002-3730-779X |
| OpenAccessLink | https://doaj.org/article/06774e45f48843f39d2d3433d0859c1a |
| PMID | 34989172 |
| PQID | 2625922958 |
| PQPubID | 4370305 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_06774e45f48843f39d2d3433d0859c1a pubmedcentral_primary_oai_pubmedcentral_nih_gov_8818609 proquest_miscellaneous_2617276347 proquest_journals_2625922958 pubmed_primary_34989172 crossref_primary_10_1002_jcsm_12890 crossref_citationtrail_10_1002_jcsm_12890 wiley_primary_10_1002_jcsm_12890_JCSM12890 |
| PublicationCentury | 2000 |
| PublicationDate | February 2022 |
| PublicationDateYYYYMMDD | 2022-02-01 |
| PublicationDate_xml | – month: 02 year: 2022 text: February 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Heidelberg – name: Hoboken |
| PublicationTitle | Journal of cachexia, sarcopenia and muscle |
| PublicationTitleAlternate | J Cachexia Sarcopenia Muscle |
| PublicationYear | 2022 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2015; 35 2018; 485 2002; 15 1997; 315 2021; 21 2002; 50 2013; 23 2019; 10 2019; 15 2016; 388 2014; 69 2011; 12 2014; 29 2008; 73 2016; 38 2003; 51 2003; 95 2013; 18 2018; 6 2009; 58 2003; 327 2021; 34 2017; 71 2017; 37 2019; 20 2017; 36 2008; 27 2014; 15 2019; 29 2014; 18 2018; 72 2009; 361 2014; 9 2021; 40 2018; 31 2012; 65 2018; 38 2014; 56 2014; 10 2018; 28 2009; 62 2019; 73 2011; 2 2015; 18 2009; 64 2010; 39 2017; 27 2019; 34 2015; 10 2006; 151 1997; 29 2008; 56 2005; 81 2018; 61 2014; 85 2018; 19 2004; 159 2017; 92 2019; 42 2020; 30 2020 2021; 18 2015 1998; 147 2020; 21 2018; 93 2009; 4 2018; 12 1994; 50 2020; 119 2012; 41 2016; 23 2018; 13 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_69_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 e_1_2_10_70_1 e_1_2_10_2_1 e_1_2_10_72_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_74_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_76_1 Braun T (e_1_2_10_9_1) 2019; 15 e_1_2_10_55_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_57_1 e_1_2_10_78_1 e_1_2_10_58_1 e_1_2_10_13_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 e_1_2_10_80_1 e_1_2_10_61_1 e_1_2_10_29_1 e_1_2_10_63_1 e_1_2_10_27_1 e_1_2_10_65_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_67_1 e_1_2_10_24_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 Medeiros MCW (e_1_2_10_45_1) 2020 e_1_2_10_71_1 As'habi A (e_1_2_10_34_1) 2018; 12 e_1_2_10_73_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_75_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_77_1 e_1_2_10_56_1 e_1_2_10_79_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_59_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 e_1_2_10_50_1 Kim C (e_1_2_10_47_1) 2020; 30 e_1_2_10_60_1 e_1_2_10_62_1 e_1_2_10_64_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_66_1 e_1_2_10_26_1 e_1_2_10_68_1 37759413 - J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2984. doi: 10.1002/jcsm.13113. |
| References_xml | – volume: 42 start-page: 1437 year: 2019 end-page: 1445 article-title: Sarcopenia in chronic kidney disease: factors, mechanisms, and therapeutic interventions publication-title: Biol Pharm Bull – volume: 327 start-page: 557 year: 2003 end-page: 560 article-title: Measuring inconsistency in meta‐analyses publication-title: Br Med J – volume: 34 start-page: 1347 year: 2021 end-page: 1372 article-title: Sarcopenia in chronic kidney disease: what have we learned so far? publication-title: J Nephrol – volume: 81 start-page: 543 year: 2005 end-page: 554 article-title: Survival advantages of obesity in dialysis patients publication-title: Am J Clin Nutr – volume: 30 start-page: 313 year: 2020 end-page: 321 article-title: Estimating the prevalence of muscle wasting, weakness, and sarcopenia in hemodialysis patients publication-title: J Ren Nutr – volume: 21 start-page: 281 year: 2020 article-title: Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients publication-title: BMC Nephrol – volume: 34 start-page: 802 year: 2019 end-page: 810 article-title: Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis publication-title: Nephrol Dial Transplant – volume: 15 start-page: 95 year: 2014 end-page: 101 article-title: Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia publication-title: J Am Med Dir Assoc – volume: 72 start-page: 993 year: 2018 end-page: 999 article-title: Differences in the prevalence of sarcopenia in peritoneal dialysis patients using hand grip strength and appendicular lean mass: depends upon guideline definitions publication-title: Eur J Clin Nutr – volume: 51 start-page: 1602 year: 2003 end-page: 1609 article-title: Sarcopenia: alternative definitions and associations with lower extremity function publication-title: J Am Geriatr Soc – volume: 10 start-page: 1192 year: 2015 end-page: 1200 article-title: Body composition and survival in dialysis patients: results from an international cohort study publication-title: Clin J Am Soc Nephrol – volume: 23 start-page: 315 year: 2016 end-page: 323 article-title: PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer publication-title: Cell Metab – volume: 18 start-page: 368 year: 2013 end-page: 379 article-title: Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass publication-title: Cell Metab – volume: 73 start-page: 391 year: 2008 end-page: 398 article-title: A proposed nomenclature and diagnostic criteria for protein‐energy wasting in acute and chronic kidney disease publication-title: Kidney Int – volume: 151 start-page: 165 year: 2006 end-page: 174 article-title: Adipose tissue and inflammation in chronic kidney disease publication-title: Contrib Nephrol – volume: 38 start-page: 364 year: 2016 end-page: 371 article-title: Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk publication-title: Ren Fail – volume: 13 year: 2018 article-title: Reference values for hand grip strength in the South Korean population publication-title: PLoS ONE – volume: 9 start-page: 1720 year: 2014 end-page: 1728 article-title: Comparative associations of muscle mass and muscle strength with mortality in dialysis patients publication-title: Clin J Am Soc Nephrol – volume: 18 year: 2021 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: PLoS Med – volume: 50 start-page: 889 year: 2002 end-page: 896 article-title: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability publication-title: J Am Geriatr Soc – volume: 159 start-page: 413 year: 2004 end-page: 421 article-title: Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women publication-title: Am J Epidemiol – volume: 4 year: 2009 article-title: Dual energy X‐ray absorptiometry body composition reference values from NHANES publication-title: Plos One – volume: 50 start-page: 1088 year: 1994 end-page: 1101 article-title: Operating characteristics of a rank correlation test for publication bias publication-title: Biometrics – volume: 36 start-page: 1654 year: 2017 end-page: 1660 article-title: The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients publication-title: Clin Nutr – volume: 41 start-page: 297 year: 2012 end-page: 322 article-title: Multifaceted role of insulin‐like growth factors and mammalian target of rapamycin in skeletal muscle publication-title: Endocrinol Metab Clin North Am – volume: 85 start-page: 158 year: 2014 end-page: 165 article-title: Worldwide, mortality risk is high soon after initiation of hemodialysis publication-title: Kidney Int – volume: 61 start-page: 168 year: 2018 end-page: 181 article-title: Obesity paradox in advanced kidney disease: from bedside to the bench publication-title: Prog Cardiovasc Dis – volume: 10 start-page: 1143 year: 2019 end-page: 1145 article-title: Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019 publication-title: J Cachexia Sarcopenia Muscle – volume: 38 start-page: 447 year: 2018 end-page: 454 article-title: Sarcopenia and frailty in PD: impact on mortality, malnutrition, and inflammation publication-title: Perit Dial Int – volume: 92 start-page: 238 year: 2017 end-page: 247 article-title: Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis publication-title: Kidney Int – volume: 39 start-page: 412 year: 2010 end-page: 423 article-title: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People publication-title: Age Ageing – volume: 23 start-page: 77 year: 2013 end-page: 90 article-title: Etiology of the protein‐energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM) publication-title: J Ren Nutr – volume: 31 start-page: 689 year: 2018 end-page: 696 article-title: Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity publication-title: J Hum Nutr Diet – volume: 28 start-page: 197 year: 2018 end-page: 207 article-title: Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis publication-title: J Ren Nutr – volume: 29 start-page: 584 year: 1997 end-page: 592 article-title: Quality of life in patients on chronic dialysis: self‐assessment 3 months after the start of treatment. The Necosad Study Group publication-title: Am J Kidney Dis – year: 2015 – volume: 12 start-page: 53 year: 2018 end-page: 60 article-title: Prevalence of sarcopenia and dynapenia and their determinants in Iranian peritoneal dialysis patients publication-title: Iran J Kidney Dis – volume: 65 start-page: 934 year: 2012 end-page: 939 article-title: Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement publication-title: J Clin Epidemiol – volume: 18 start-page: 710 year: 2014 end-page: 717 article-title: Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria publication-title: J Nutr Health Aging – volume: 21 start-page: 27 year: 2021 end-page: 33 article-title: Brain‐derived neurotrophic factor is associated with sarcopenia and frailty in Japanese hemodialysis patients publication-title: Geriatr Gerontol Int – volume: 27 start-page: 601 year: 2008 end-page: 607 article-title: Reference values of handgrip dynamometry of healthy adults: a population‐based study publication-title: Clin Nutr – volume: 62 start-page: e1 year: 2009 end-page: e34 article-title: The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: J Clin Epidemiol – volume: 19 start-page: 259 year: 2018 article-title: High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy—an observational cross‐sectional study publication-title: BMC Nephrol – volume: 30 start-page: 30 year: 2020 article-title: Longitudinal changes in body composition are associated with all‐cause mortality in patients on peritoneal dialysis publication-title: Clin Nutr – volume: 64 start-page: 1183 year: 2009 end-page: 1189 article-title: Higher inflammatory marker levels in older persons: associations with 5‐year change in muscle mass and muscle strength publication-title: J Gerontol A Biol Sci Med Sci – volume: 72 start-page: 1455 year: 2018 end-page: 1457 article-title: Estimation of lean body mass by creatinine kinetics increases the prevalence of muscle wasting in peritoneal dialysis patients compared to bioimpedance publication-title: Eur J Clin Nutr – volume: 119 start-page: 1219 year: 2020 end-page: 1229 article-title: Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: a 3‐year longitudinal study publication-title: J Formos Med Assoc – volume: 12 start-page: 249 year: 2011 end-page: 256 article-title: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences publication-title: J Am Med Dir Assoc – volume: 18 start-page: 254 year: 2015 end-page: 262 article-title: Latest consensus and update on protein‐energy wasting in chronic kidney disease publication-title: Curr Opin Clin Nutr Metab Care – volume: 315 start-page: 629 year: 1997 end-page: 634 article-title: Bias in meta‐analysis detected by a simple, graphical test publication-title: Bmj‐British Med J – volume: 35 start-page: 216 year: 2015 end-page: 221 article-title: Peritoneal protein clearance rather than faster transport status determines outcomes in peritoneal dialysis patients publication-title: Perit Dial Int – volume: 361 start-page: 1539 year: 2009 end-page: 1547 article-title: Functional status of elderly adults before and after initiation of dialysis publication-title: N Engl J Med – volume: 71 start-page: 1405 year: 2017 end-page: 1410 article-title: Low appendicular muscle mass is associated with mortality in peritoneal dialysis patients: a single‐center cohort study publication-title: Eur J Clin Nutr – volume: 71 start-page: 70 year: 2017 end-page: 75 article-title: Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance publication-title: Eur J Clin Nutr – volume: 56 start-page: 1710 year: 2008 end-page: 1715 article-title: Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community‐dwelling elderly people in Taiwan publication-title: J Am Geriatr Soc – volume: 485 start-page: 113 year: 2018 end-page: 118 article-title: Decreased serum fatty acid binding protein 4 concentrations are associated with sarcopenia in chronic hemodialysis patients publication-title: Clin Chim Acta – volume: 34 start-page: 599 year: 2019 end-page: 607 article-title: Impact of sarcopenia on long‐term mortality and cardiovascular events in patients undergoing hemodialysis publication-title: Korean J Intern Med – volume: 10 start-page: 504 year: 2014 end-page: 516 article-title: Mechanisms of muscle wasting in chronic kidney disease publication-title: Nat Rev Nephrol – volume: 2 start-page: 119 year: 2011 article-title: Wasting in chronic kidney disease (vol 2, pg 9, 2011) publication-title: J Cachexia Sarcopeni – volume: 34 start-page: 465 year: 2021 end-page: 471 article-title: Feasibility of computed tomography‐based assessment of skeletal muscle mass in hemodialysis patients publication-title: J Nephrol – volume: 56 start-page: 415 year: 2014 end-page: 425 article-title: Obesity paradox in end‐stage kidney disease patients publication-title: Prog Cardiovasc Dis – volume: 95 start-page: 1851 year: 2003 end-page: 1860 article-title: Age‐associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia publication-title: J Appl Physiol – volume: 37 start-page: 78 year: 2017 end-page: 84 article-title: Shortage of appendicular skeletal muscle is an independent risk factor for mortality in peritoneal dialysis patients publication-title: Perit Dial Int – year: 2020 article-title: Serum sclerostin, body composition, and sarcopenia in hemodialysis patients with diabetes publication-title: Int J Nephrol – volume: 93 start-page: 430 year: 2018 end-page: 438 article-title: Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one‐year course publication-title: Kidney Int – volume: 58 start-page: 2506 year: 2009 end-page: 2515 article-title: 11 β‐Hydroxysteroid dehydrogenase type 1 regulates glucocorticoid‐induced insulin resistance in skeletal muscle publication-title: Diabetes – volume: 40 start-page: 1161 year: 2021 end-page: 1167 article-title: The clinical applicability of ultrasound technique for diagnosis of sarcopenia in hemodialysis patients publication-title: Clin Nutr – volume: 20 start-page: 1 year: 2019 end-page: 7 article-title: Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis publication-title: BMC Nephrol – volume: 29 start-page: 1390 year: 2019 end-page: 1399 article-title: Prevalence of obesity and obesity‐associated muscle wasting in patients on peritoneal dialysis publication-title: Nutr Metab Cardiovas – volume: 69 start-page: 547 year: 2014 end-page: 558 article-title: The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates publication-title: J Gerontol A Biol Sci Med Sci – volume: 27 start-page: 84 year: 2017 end-page: 90 article-title: Sarcopenic obesity definitions by body composition and mortality in the hemodialysis patients publication-title: J Ren Nutr – volume: 147 start-page: 755 year: 1998 end-page: 763 article-title: Epidemiology of sarcopenia among the elderly in New Mexico publication-title: Am J Epidemiol – volume: 15 start-page: 92 year: 2019 article-title: Sarcopenia: revised European consensus on definition and diagnosis publication-title: Phys Ther – volume: 21 start-page: 300 year: 2020 end-page: 7 e2 article-title: Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment publication-title: J Am Med Dir Assoc – volume: 15 start-page: 329 year: 2002 end-page: 337 article-title: Inflammation in end‐stage renal disease: sources, consequences, and therapy publication-title: Semin Dial – volume: 6 start-page: 161 year: 2018 article-title: Malnutrition in chronic kidney disease publication-title: Front Pediatr – volume: 388 start-page: 294 year: 2016 end-page: 306 article-title: Factors affecting outcomes in patients reaching end‐stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices publication-title: Lancet – volume: 29 start-page: 1655 year: 2014 end-page: 1665 article-title: Uraemic sarcopenia: aetiology and implications publication-title: Nephrol Dial Transplant – volume: 73 start-page: 1209 year: 2019 end-page: 1211 article-title: Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis? publication-title: Eur J Clin Nutr – ident: e_1_2_10_29_1 doi: 10.3747/pdi.2017.00271 – ident: e_1_2_10_77_1 doi: 10.1152/japplphysiol.00246.2003 – ident: e_1_2_10_53_1 doi: 10.1016/j.cmet.2013.07.012 – ident: e_1_2_10_11_1 doi: 10.1016/j.jamda.2019.12.012 – ident: e_1_2_10_24_1 doi: 10.2215/CJN.10261013 – ident: e_1_2_10_33_1 doi: 10.1038/s41430-018-0238-3 – ident: e_1_2_10_70_1 doi: 10.1093/aje/kwh058 – ident: e_1_2_10_6_1 doi: 10.1038/nrneph.2014.112 – ident: e_1_2_10_25_1 doi: 10.3109/0886022X.2015.1132173 – ident: e_1_2_10_27_1 doi: 10.1038/ejcn.2016.202 – ident: e_1_2_10_61_1 doi: 10.2337/db09-0525 – ident: e_1_2_10_72_1 doi: 10.1046/j.1532-5415.2003.51534.x – ident: e_1_2_10_15_1 doi: 10.1016/j.clnu.2020.07.025 – ident: e_1_2_10_49_1 doi: 10.1111/ggi.14089 – ident: e_1_2_10_68_1 doi: 10.1016/j.pcad.2018.07.001 – ident: e_1_2_10_60_1 doi: 10.1016/j.cmet.2015.11.003 – ident: e_1_2_10_14_1 doi: 10.1038/s41430-019-0468-z – ident: e_1_2_10_36_1 doi: 10.1053/j.jrn.2017.12.003 – ident: e_1_2_10_32_1 doi: 10.1053/j.jrn.2016.09.010 – ident: e_1_2_10_40_1 doi: 10.1093/ndt/gfy252 – ident: e_1_2_10_52_1 doi: 10.1038/sj.ki.5002585 – ident: e_1_2_10_26_1 doi: 10.1016/j.clnu.2016.10.016 – ident: e_1_2_10_2_1 doi: 10.1016/S0140-6736(16)30448-2 – ident: e_1_2_10_35_1 doi: 10.1186/s12882-018-1055-6 – ident: e_1_2_10_69_1 doi: 10.1016/j.pcad.2013.10.005 – ident: e_1_2_10_18_1 – ident: e_1_2_10_73_1 doi: 10.1093/oxfordjournals.aje.a009520 – ident: e_1_2_10_42_1 doi: 10.1016/j.jfma.2019.10.020 – ident: e_1_2_10_16_1 doi: 10.1371/journal.pmed.1003583 – ident: e_1_2_10_76_1 doi: 10.2215/CJN.08550814 – ident: e_1_2_10_7_1 doi: 10.1007/s40620-020-00840-y – ident: e_1_2_10_80_1 doi: 10.1002/jcsm.12501 – ident: e_1_2_10_50_1 doi: 10.1007/s40620-020-00871-5 – ident: e_1_2_10_71_1 doi: 10.1111/j.1532-5415.2008.01854.x – ident: e_1_2_10_4_1 doi: 10.1046/j.1525-139X.2002.00083.x – ident: e_1_2_10_48_1 doi: 10.1186/s12882-020-01937-z – ident: e_1_2_10_64_1 doi: 10.1016/j.kint.2017.07.022 – ident: e_1_2_10_31_1 doi: 10.1016/j.kint.2017.01.024 – ident: e_1_2_10_5_1 doi: 10.3747/pdi.2013.00217 – ident: e_1_2_10_56_1 doi: 10.1007/s13539-011-0026-6 – ident: e_1_2_10_57_1 doi: 10.1159/000095327 – volume: 12 start-page: 53 year: 2018 ident: e_1_2_10_34_1 article-title: Prevalence of sarcopenia and dynapenia and their determinants in Iranian peritoneal dialysis patients publication-title: Iran J Kidney Dis – ident: e_1_2_10_79_1 doi: 10.1016/j.clnu.2008.04.004 – ident: e_1_2_10_21_1 doi: 10.1136/bmj.315.7109.629 – ident: e_1_2_10_38_1 doi: 10.1111/jhn.12555 – ident: e_1_2_10_19_1 doi: 10.1016/j.jclinepi.2011.11.014 – ident: e_1_2_10_8_1 doi: 10.1093/ageing/afq034 – ident: e_1_2_10_55_1 doi: 10.1093/gerona/glp097 – ident: e_1_2_10_54_1 doi: 10.1248/bpb.b19-00513 – ident: e_1_2_10_78_1 doi: 10.1371/journal.pone.0195485 – volume: 15 start-page: 92 year: 2019 ident: e_1_2_10_9_1 article-title: Sarcopenia: revised European consensus on definition and diagnosis publication-title: Phys Ther – ident: e_1_2_10_23_1 doi: 10.1007/s12603-014-0505-5 – ident: e_1_2_10_37_1 doi: 10.1016/j.cca.2018.06.025 – ident: e_1_2_10_12_1 doi: 10.1093/gerona/glu010 – ident: e_1_2_10_28_1 doi: 10.3747/pdi.2016.00019 – ident: e_1_2_10_58_1 doi: 10.1053/j.jrn.2013.01.001 – ident: e_1_2_10_30_1 doi: 10.1038/ejcn.2017.104 – ident: e_1_2_10_67_1 doi: 10.1093/ajcn/81.3.543 – ident: e_1_2_10_63_1 doi: 10.1016/S0272-6386(97)90342-5 – ident: e_1_2_10_20_1 doi: 10.1136/bmj.327.7414.557 – volume: 30 start-page: 30 year: 2020 ident: e_1_2_10_47_1 article-title: Longitudinal changes in body composition are associated with all‐cause mortality in patients on peritoneal dialysis publication-title: Clin Nutr – ident: e_1_2_10_66_1 doi: 10.1038/ki.2013.252 – ident: e_1_2_10_43_1 doi: 10.1186/s12882-019-1271-8 – ident: e_1_2_10_46_1 doi: 10.1053/j.jrn.2019.09.004 – ident: e_1_2_10_10_1 doi: 10.1016/j.jamda.2013.11.025 – ident: e_1_2_10_39_1 doi: 10.1038/s41430-017-0072-z – ident: e_1_2_10_51_1 doi: 10.1097/MCO.0000000000000171 – ident: e_1_2_10_59_1 doi: 10.1016/j.ecl.2012.04.012 – ident: e_1_2_10_65_1 doi: 10.1056/NEJMoa0904655 – ident: e_1_2_10_3_1 doi: 10.1093/ndt/gft070 – ident: e_1_2_10_44_1 doi: 10.1016/j.numecd.2019.05.057 – ident: e_1_2_10_13_1 doi: 10.1016/j.jamda.2011.01.003 – ident: e_1_2_10_17_1 doi: 10.1016/j.jclinepi.2009.06.006 – ident: e_1_2_10_74_1 doi: 10.1371/journal.pone.0007038 – ident: e_1_2_10_75_1 doi: 10.1046/j.1532-5415.2002.50216.x – ident: e_1_2_10_41_1 doi: 10.3904/kjim.2017.083 – ident: e_1_2_10_22_1 doi: 10.2307/2533446 – year: 2020 ident: e_1_2_10_45_1 article-title: Serum sclerostin, body composition, and sarcopenia in hemodialysis patients with diabetes publication-title: Int J Nephrol – ident: e_1_2_10_62_1 doi: 10.3389/fped.2018.00161 – reference: 37759413 - J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2984. doi: 10.1002/jcsm.13113. |
| SSID | ssj0000461650 |
| Score | 2.6222973 |
| SecondaryResourceType | review_article |
| Snippet | There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review aimed to... There is no consensus on the prevalence of sarcopenia or its impact on mortality in end-stage renal disease patients undergoing dialysis. This review aimed to... Abstract There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐stage renal disease patients undergoing dialysis. This review... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 145 |
| SubjectTerms | Aged Bias Body Composition Diagnosis Dialysis Humans Kidney transplants Meta-analysis Middle Aged Mortality Muscle Strength Peritoneal dialysis Prevalence Renal Dialysis - adverse effects Review Reviews Sarcopenia Sarcopenia - diagnosis Sarcopenia - epidemiology Sarcopenia - etiology Systematic review Working groups |
| SummonAdditionalLinks | – databaseName: ProQuest Publicly Available Content dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ1Nb9QwEIZHsEWIC-WzhBZkBBdQzW5sJ3G4IChUgLTVSoBUTpHXHyWIJstmy-_H43hTVlQ9cYsSK4o14_Hr2PMMwDOtTSb9PEiz0mgqmOBUKeOo82p0ro2fMZQLxSaKoyN5fFzOYnp0F49VrmNiCNQ97RnPbfsgPDatxj_mY4ayHStRy9eLXxRrSOFeayyocRW2ELw1GcHW7ON09m3454Jw8TwUbWWYQZ15bTQQS9n4h-5OX6a48bYxRwWU_0X6899jlH_L2zA_HW7_357dgptRp5I3vWPdhiu2uQPXp3En_i407_ozenW3TxZLZIZjiNgnqjHkNEh6L-9J60jnRxKW6KoVqRuCaSrIQCGR59q9Ioqc06RJn0nTv8WuFFWRmXIPvh6-_3LwgcbaDVRnXoNSxeb5RBu_npKqULoo3DzNNbPeG5iVZWalm6SWi1yk3lOsUuncr9yMK6TQPujk_D6MmraxD4A4VTiRpdwhSd75FxmveUypC6swopgEnq-tVekINsf6Gj-rHsnMKrRsFSybwNOh7aLHeVzY6i0afWiBCO5wo12eVHFEV4jeE1ZkzodAwR0vDTNccG4QGadTlcDe2txVjAtddW7dBJ4Mj_2Ixm0a1dj2DNugqMy5KBLY6T1s-BIuSukX2CyBYsP3Nj5180lTfw_UcInswkmZwIvgpZd0v_p08Hkarh5e3odduMEwGyQcYt-D0Wp5Zh_BNf17VXfLx3H0_QEBOkCX priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1Lb9QwEMdHpSDUC29KoCAjuIAaun4kdhAXKFQIqVUlQOrNcvyAIJpdbbac-Qh8Rj4JHiebZUWFhLitNpMoiWfsv2PPbwAeW-sKFcfBvKiczQUTPDfGhTxENVpbF0cME1KxCXl0pE5OquMNeLHMhen5EOMHN4yM1F9jgJu621tBQ7_Y7vQZxXWyC3CRUi7Rp5k4Hr-wIEq8TCVaGeZLF1EJjXxStrc6fW1ESuD-89Tmn5smfxezaTQ6uPp_z3ENrgwqlLzs3eY6bPj2Blw-HNbZb8Lsdb8Dr-l2yWyORHDsAHaJaR05TYI9incyDaSLcYIFuBpDmpZgEgoSTshAa-2eE0NWrGjS58n0V_EL8_P7DzMwUW7Bx4M3H_bf5kNthtwWUWPmhtXlxLo4X1JGGitlqGlpmY-tzbyqCq_ChHouSkGjJ3hjaB1nZi5IJWzsVEp-GzbbaevvAAlGBlFQHpAUH-KFXNQ0rrLSG-wxXAZPlu2j7QAux_oZX3WPXGYaX6FOrzCDR6PtrMd1nGv1Cpt5tEDEdvpjOv-kh4jViNYTXhQhdnGCB1455rjg3CESzlKTwc7SSfQQ951mOJ3ECukqg4fj4RixuAxjWj89QxsUjSUXMoPt3qfGO-GiUnECzTKQa962dqvrR9rmc6KCK2QTTqoMniZv-8vj63f77w_Tr7v_YnwPthjmfqQt6zuwuZif-ftwyX5bNN38QYq9Xw9vNCk priority: 102 providerName: Wiley-Blackwell |
| Title | Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcsm.12890 https://www.ncbi.nlm.nih.gov/pubmed/34989172 https://www.proquest.com/docview/2625922958 https://www.proquest.com/docview/2617276347 https://pubmed.ncbi.nlm.nih.gov/PMC8818609 https://doaj.org/article/06774e45f48843f39d2d3433d0859c1a |
| Volume | 13 |
| WOSCitedRecordID | wos000739132300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals (DOAJ) customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 7X7 dateStart: 20100901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: BENPR dateStart: 20100901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: PIMPY dateStart: 20100901 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: WIN dateStart: 20100101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 24P dateStart: 20100101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BQagXxJtAWRnBBdTQje3ECTdaWlGkXa14iOUUef0QqWh2tdly5ifwG_klzDhp2BUVXLhYSWxZjmfG_kYefwPw1Bib5rgPxmlhTSy5FLHW1sce0ejMWNwxtA_JJtR4nE-nxWQt1RfFhLX0wO3E7RHDmXQy9ahpUnhRWG6FFMISM5dJAjQaqmLNmQprsMySLKRn5XRXOkUU1HOT8r0T05y-SOiIbWM3CqT9FyHNPwMm14Fs2ImObsD1DkKyV-3Qb8IlV9-Ca6PukPw2LF634XNVs8sWS6LzJuvdZbq27DSgbUTebO5Zg0pO2bMqzaqa0Q0SoidhHdVq85Jp9pvombWXXNpe3Er__P5Dd4Qmd-Dj0eGHgzdxl1ghNikCxFjzWTY0Fp2dXCttlPKzJDPcoai4y4vU5X6YOCEzmaAYndbJDN0q61UuDa4ImbgLW_W8dveBea28TBPhiebdY0cWAYktjHKazN1G8Ox8gkvTsY5T8ouvZcuXzEsSRhmEEcGTvu2i5dq4sNU-yalvQfzY4QNqTdlpTfkvrYlg51zKZWe0TcnJF6T05nkEj_tqNDc6Q9G1m59RG0J8mZAqgnutUvQjEbLI0fvlEagNddkY6mZNXX0JlN45EQsOiwieB8X6y--Xbw_ej8LTg_8xEQ9hm9OFjhCHvgNbq-WZewRXzbdV1SwHcJnLCZZqqkKZD-DK_uF48m4QzA3fJsejyWd8-3Q8_gWAwyz9 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VFAEX3o-FAkbAAdSlWdv7QkIIWqqGNlWkFqmcFscPCKKbkE1B_Cl-IzPezZaIqrceuK3WlmUn34w_r2e-AXiitYkz3AfDODc6lFyKUCnjQodsdKgN7hjK-WIT6e5udnCQD5bg9zwXhsIq5z7RO2oz1vSNfI0TUafa09nryfeQqkbR7eq8hEYNi2376yce2apXvQ38f59yvvluf30rbKoKhDpGdhQqPky62iDTz1SqdJq6YZRobnGe3GZ5bDPXjayQiYxwDVapaIhnCuPSTGo0h0TguOdgWSLYux1YHvT6g4_tVx2SL098WVhOOdoxsq9WE5WvfdXV4YuIrvYWdkFfLOAkhvtvoObfBNrvgJtX_rff7ipcbrg2e1MbxzVYsuV1uNBvogluQLlRxxmOqlU2mZLuObm5VaZKww79sQSPKGzsWIVTpzJjI8VGJaNUG9JxYY0mbfWSKXasiM3qbKB6FDtToWp0X27ChzNZ7S3olOPS3gHmVOpkHAlHavgOBzLI20yuU6vIK5oAns3xUOhGnJ1qhHwrallpXhB2Co-dAB63fSe1JMmJvd4SrNoeJCPuX4ynn4vGKxUkHyitjB26cSmcyA03QgphSPZORyqAlTmgisa3VcUxmgJ41DajV6KrJlXa8RH1IWKcCJkGcLvGcDsTIfMsx-YA0gV0L0x1saUcffHK5xnpL3bzAJ57Ozhl-cX79b2-f7p7-hoewsWt_f5OsdPb3b4Hlzhlt_ig_BXozKZH9j6c1z9mo2r6oLF1Bp_O2kT-AHGoj_0 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VFFVceD8WChgBB1CXZG3vCwkh2jSilEYVD6m3xfEDgugmZFMQf41fx4x3syWi6q0HblHWsuxkZvzNeub7AB5pbeIMz8Ewzo0OJZciVMq40CEaHWmDJ4ZyXmwiHQ6zg4N8fwV-L3phqKxyERN9oDYTTe_Iu5yAOmlPZ13XlEXs9wcvp99DUpCim9aFnEZtIrv2109M36oXO338rx9zPtj-sPU6bBQGQh0jUgoVHyU9bRD1ZypVOk3dKEo0t7hmbrM8tpnrRVbIREa4H6tUNML8wrg0kxpdIxE47zlYTQUmPR1Y3dwe7r9r3_AQlXniJWI59WvHiMRaflTe_aqrw2cRXfMtnYheOOAktPtv0ebfYNqfhoNL__PveBkuNhicvaqd5gqs2PIqrO01VQbXoOzX9YfjaoNNZ8SHTuFvg6nSsEOfrmDqwiaOVbh0kh8bKzYuGbXgEL8La7hqq-dMsWOmbFZ3CdWz2LkKVcMHcx0-nslub0CnnJT2FjCnUifjSDhiyXc4kUE8Z3KdWkXR0gTwZGEbhW5I20k75FtR003zguyo8HYUwMN27LSmKjlx1CaZWDuC6MX9F5PZ56KJVgXRCkorY4fhXQoncsONkEIYosPTkQpgfWFcRRPzquLYsgJ40D7GaEVXUKq0kyMaQ4A5ETIN4GZtz-1KhMwz9CMeQLpk6UtLXX5Sjr94RvSMeBl7eQBPvU-csv3izdb7Pf_p9ul7uA9r6BfF253h7h24wKnpxdfqr0NnPjuyd-G8_jEfV7N7jdsz-HTWHvIHjHGYlw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis%2C+prevalence%2C+and+mortality+of+sarcopenia+in+dialysis+patients%3A+a+systematic+review+and+meta-analysis&rft.jtitle=Journal+of+cachexia%2C+sarcopenia+and+muscle&rft.au=Shu%2C+Xiaoyu&rft.au=Lin%2C+Taiping&rft.au=Wang%2C+Hui&rft.au=Zhao%2C+Yanli&rft.date=2022-02-01&rft.eissn=2190-6009&rft.volume=13&rft.issue=1&rft.spage=145&rft_id=info:doi/10.1002%2Fjcsm.12890&rft_id=info%3Apmid%2F34989172&rft.externalDocID=34989172 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2190-5991&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2190-5991&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2190-5991&client=summon |